Errant Gene Therapeutics, LLC™ (EGT) is a privately held biopharmaceutical company established in 2003. The company’s mission is the development of treatments for life-threatening diseases with a special focus on rare diseases, commonly referred to as “orphan diseases.” EGT is developing its portfolio of pharmaceutical products to correct the erroneous gene expression associated with many [...]